CTI BioPharma Corp. (CTIC)

AI Score

Unlock

9.10

0.01 (0.11%)

At close: Jun 23, 2023, 7:58 PM

CTI BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	24.21M	30.42M	32.05M	66.09M	96.9M	65.45M	95.28M	71.88M	33.1M	40.39M	45.3M	70.11M	81.15M	31.14M	34.92M	35.36M	40.59M	36.44M	52.91M	65.37M	104.63M	27.22M	52.8M	74.74M	33.28M	44M	61.59M	76.71M	104.64M
Short-Term Investments	34.8M	49.52M	49.59M	29.78M	n/a	n/a	n/a	n/a	4.06M	12.06M	12.11M	n/a	n/a	2.52M	11.81M	18.3M	21.66M	30.6M	28M	27.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.23M	1.23M	512K	512K	511K	-6.48M	770K	770K	985K	1.05M	1.1M	1.1M	1.15M	6.09M	5.28M	5.51M	5.65M	5.55M	5.39M	5.45M	5.73M	5.6M	5.5M	5.33M	5.06M	5M	5.35M	5.32M	5.88M
Receivables	22.96M	15.39M	10.59M	8.16M	2.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4K	180K	480K	311K	378K	620K	559K	666K
Inventory	777K	733K	1.15M	702K	102K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	564K	550K	601K	1.51M	1.5M	1.52M	2.6M	2.63M	2.91M
Other Current Assets	3.71M	3.34M	3.56M	2.64M	3.85M	2.93M	3.77M	2.94M	2.18M	1.87M	1.28M	1.42M	1.49M	1.91M	2.94M	2.97M	3.33M	15.45M	1.38M	2.23M	2.56M	19.15M	3.92M	1.64M	1.67M	9.92M	3.1M	9.01M	5.72M
Total Current Assets	86.45M	99.4M	96.94M	107.37M	103.28M	68.38M	99.05M	74.82M	39.35M	54.33M	58.69M	71.53M	82.64M	35.58M	49.67M	56.63M	65.58M	82.49M	82.3M	95.06M	107.75M	46.92M	57.5M	78.36M	36.77M	55.82M	67.92M	88.9M	113.94M
Property-Plant & Equipment	1.89M	2.08M	2.26M	2.36M	2.83M	3.29M	1.42M	1.91M	2.46M	2.87M	3.3M	3.78M	4.19M	4.61M	3.64M	4.09M	4.54M	1.79M	1.94M	2.08M	2.23M	2.37M	2.53M	2.64M	2.83M	3.02M	3.22M	3.41M	3.62M
Goodwill & Intangibles	22.7M	23.23M	23.76M	24.29M	24.82M	7.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	25.82M	26.53M	26.53M	27.16M	28.15M	4.05M	2.19M	2.68M	3.44M	3.92M	4.4M	4.88M	5.34M	10.7M	8.91M	9.61M	10.18M	7.34M	7.33M	7.53M	7.97M	7.96M	8.03M	7.97M	7.89M	8.02M	8.57M	8.73M	9.5M
Total Assets	112.27M	125.92M	123.47M	134.53M	131.44M	72.43M	101.23M	77.5M	42.79M	58.24M	63.09M	76.41M	87.98M	46.28M	58.58M	66.24M	75.77M	89.83M	89.63M	102.59M	115.72M	54.89M	65.53M	86.33M	44.66M	63.84M	76.49M	97.63M	123.44M
Account Payables	2.02M	2.01M	2.44M	3.1M	2.42M	3.89M	1.78M	1.29M	1.17M	1.64M	191K	658K	905K	n/a	2.96M	1.09M	1.12M	4.5M	2.08M	3.71M	2.19M	2.59M	2.02M	4.01M	11.88M	7.23M	13.66M	14.03M	17.71M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	441K	806K	915K	912K	872K	1.32M	304K	103K	224K	467K	646K
Short-Term Debt	48.08M	47.94M	n/a	n/a	48.34M	48.54M	48.62M	3.99M	5.53M	4.46M	5.66M	4.81M	4.81M	4.81M	10.47M	4.81M	4.81M	4.81M	3.92M	2.59M	1.26M	444K	7.77M	8.42M	8.17M	7.95M	7.72M	7.5M	7.29M
Other Current Liabilities	18.12M	31.18M	27.33M	26.69M	48.16M	14.22M	11.94M	10.5M	8.86M	10.95M	8.67M	8.28M	8.69M	13.68M	14.48M	12.07M	10.29M	13.74M	16.55M	15.13M	15.87M	15.31M	15.54M	22.71M	21.52M	25.37M	24.7M	18.76M	20.71M
Total Current Liabilities	68.23M	81.13M	29.77M	29.79M	98.93M	66.65M	62.34M	15.79M	15.56M	17.04M	14.52M	13.74M	14.4M	18.49M	27.92M	17.98M	16.22M	23.05M	23M	22.24M	20.24M	19.26M	26.2M	36.46M	41.87M	40.65M	46.3M	40.75M	46.35M
Long-Term Debt	n/a	n/a	47.8M	49.3M	n/a	2.02M	n/a	n/a	n/a	800K	1.38M	3.99M	5.73M	7.45M	3.5M	10.86M	12.55M	9.27M	10.47M	11.67M	12.88M	13.57M	7.02M	7.01M	9.19M	11.31M	13.38M	15.38M	17.31M
Other Long-Term Liabilities	69.39M	62.37M	62.73M	60.72M	60.42M	797K	n/a	n/a	577K	374K	374K	1.81M	1.81M	2.41M	974K	2.41M	2.41M	4.57M	4.8M	5.03M	5.25M	5.47M	3.18M	3.33M	3.48M	3.62M	3.75M	3.97M	4.1M
Total Long-Term Liabilities	69.39M	62.37M	110.53M	110.02M	60.42M	2.02M	n/a	n/a	577K	1.17M	1.75M	5.8M	7.55M	9.86M	4.47M	13.28M	14.96M	13.84M	15.27M	16.7M	18.43M	19.54M	10.92M	10.95M	13.16M	15.44M	17.67M	20.12M	22.34M
Total Liabilities	137.62M	143.5M	140.3M	139.81M	159.35M	68.67M	62.34M	15.79M	16.14M	18.21M	16.27M	19.55M	21.95M	28.35M	32.39M	31.26M	31.18M	36.89M	38.27M	38.94M	38.67M	38.8M	37.12M	47.41M	55.03M	56.09M	63.97M	60.88M	68.7M
Total Debt	48.9M	49.96M	49.24M	49.3M	48.34M	50.56M	48.62M	3.99M	5.53M	5.25M	7.04M	8.8M	10.54M	12.26M	13.97M	15.68M	17.36M	14.08M	14.39M	14.26M	14.14M	14.02M	14.79M	15.43M	17.36M	19.26M	21.09M	22.87M	24.6M
Common Stock	132K	131K	127K	114K	101K	100K	97K	93K	77K	76K	74K	74K	74K	58K	58K	58K	58K	58K	58K	58K	58K	2.22B	2.22B	2.22B	2.17B	2.17B	2.17B	2.16B	2.16B
Retained Earnings	-2.53B	-2.52B	-2.5B	-2.49B	-2.46B	-2.43B	-2.39B	-2.36B	-2.35B	-2.33B	-2.31B	-2.3B	-2.28B	-2.26B	-2.26B	-2.25B	-2.23B	-2.22B	-2.23B	-2.21B	-2.2B	-2.2B	-2.18B	-2.17B	-2.17B	-2.15B	-2.14B	-2.11B	-2.1B
Comprehensive Income	-11K	-35K	-89K	-71K	n/a	n/a	n/a	n/a	-1K	2K	3K	n/a	-11.99M	-11.99M	-10.66M	-10.62M	-10.63M	-10.64M	-9.91M	-9.9M	-6.8M	-6.27M	-6.33M	-6.44M	-6.61M	-6.66M	-6.39M	-6.45M	-6.33M
Shareholders Equity	-25.35M	-17.58M	-16.84M	-5.27M	-27.92M	3.77M	38.89M	61.71M	26.65M	40.03M	46.82M	56.86M	71.79M	23.69M	31.95M	40.74M	50.34M	58.69M	57.12M	69.39M	82.78M	21.81M	34.13M	44.61M	-4.7M	13.32M	17.89M	41.95M	59.68M
Total Investments	34.8M	49.52M	49.59M	29.78M	n/a	n/a	n/a	n/a	4.06M	12.06M	12.11M	n/a	n/a	2.52M	11.81M	18.3M	21.66M	30.6M	28M	27.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a